SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...
GENT, Belgium & MALVERN, Pa. & TOKYO, January 28, 2026--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 ...
Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer's disease causes, broadening access to quality ...
NCD Will Integrate Firefly’s BNA Technology into its Patient Management Protocols for Enhanced Brain Function Insights and Improved Patient Outcomes TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Firefly ...
Please provide your email address to receive an email when new articles are posted on . Increasing diagnoses of paraneoplastic neurologic syndromes in the U.S. correlates to heightened awareness by ...
A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, ...
HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Healio Neurology looks back at the most popular Q&As ...
TORONTO, ON / ACCESSWIRE / January 19, 2023 / AVAIL SCIENTIFIC (OTC PINK:MOBO) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which ...
(MENAFN- AETOSWire) (BUSINESS WIRE ) -- H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully ...
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE(R) G immunoassay analyzers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results